GENE THERAPY FOR SULFATASE DEFICIENCY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130172403A1
SERIAL NO

13406154

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to methods and compositions for the diagnosis and treatment of Multiple Sulfatase Deficiency (MSD) as well as other sulfatase deficiencies. More specifically, the invention relates to isolated molecules that modulate post-translational modifications on sulfatases. Such modifications are essential for proper sulfatase function.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SHIRE HUMAN GENETIC THERAPIES INC300 SHIRE WAY LEXINGTON MA 02421

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ballabio, Andrea Naples, IT 16 142
Cosma, Maria Pia Naples, IT 10 130
Dierks, Thomas Gottingen, DE 7 118
Heartlein, Michael W Boxborough, US 46 1004
Schmidt, Bernhard Gottingen, DE 119 795
von, Figura Kurt Gottingen, DE 4 58

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation